The benefits of naltrexone/bupropion (Mysimba) continue to outweigh its risks, despite ongoing uncertainty about long-term ...

The life-saving devices will see prices rise by nearly Rs 700 in some cases as the MRP is adjusted for inflation.

NPPA directed all manufacturers and importers of coronary stents whose retail prices are lower than the ceiling set by it to ...

Milestone Pharmaceuticals hit another bump in the road in its quest to get Cardamyst approved for paroxysmal supraventricular ...

Kottayam: Large quantities of the medicine Mephentermine Sulphate, which was sent by courier to be misused as a performance ...

Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, ...

HRS-5346 is currently in a Phase 2 clinical trial in China and targets Lipoprotein(a), a genetically determined and independent risk factor for atherosclerotic cardiovascular disease, which ...

The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

The largest analysis to examine the best way to lower levels of "bad" cholesterol in patients with blocked arteries shows ...

Zerodha CEO Nithin Kamath described weight-loss drugs Ozempic and Mounjaro as near 'miracle drugs,' highlighting their ...

Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for cardiovascular ...

Viagra was approved by the U.S. Food and Drug Administration 27 years ago. Experts say it immediately changed the way we talk ...